Triglyceride / HDL Ratio

← Back to Lab Reference Library

Category: Metabolic Health  |  Also known as: TG/HDL Ratio, Atherogenic Index, Triglyceride to HDL Cholesterol Ratio  |  Sample: Serum; requires fasting lipid panel (9 to 12 hr fast)

1. What This Test Measures

The Triglyceride/HDL ratio is a simple calculation derived from two values on a standard fasting lipid panel:

The ratio captures the interplay between two opposing metabolic forces:

• Triglycerides: fat particles in the bloodstream derived primarily from dietary carbohydrates and sugar (not dietary fat, as commonly believed); elevated by insulin resistance, excess carbohydrate intake, alcohol, and metabolic dysfunction
• HDL cholesterol: the cardioprotective lipoprotein that removes cholesterol from arterial walls and transports it back to the liver; suppressed by insulin resistance, physical inactivity, smoking, and excess carbohydrate intake

Insulin resistance drives both sides of this ratio in the wrong direction simultaneously, raising triglycerides and lowering HDL, making the TG/HDL ratio an exceptionally sensitive composite marker of metabolic dysfunction.

2. Why This Test Matters

• Insulin resistance surrogate: research by McLaughlin and colleagues at Stanford established that a TG/HDL ratio above 3.0 predicts insulin resistance (measured by the gold-standard hyperinsulinemic euglycemic clamp technique) with high sensitivity and specificity in non-diabetic adults. The TG/HDL ratio detects insulin resistance years before fasting glucose or HbA1c become abnormal.
• LDL particle size proxy: a TG/HDL ratio above 3.0 is strongly associated with LDL pattern B: predominance of small dense LDL particles, which are significantly more atherogenic than large buoyant LDL. Small dense LDL penetrates arterial walls more easily, oxidizes more readily, and has longer circulation time. A patient with "normal" LDL of 120 mg/dL and TG/HDL of 4.5 may have predominantly small dense, highly atherogenic particles.
• Metabolic syndrome identification: the TG/HDL ratio is one of the most sensitive components of metabolic syndrome criteria and often becomes abnormal before other components meet diagnostic thresholds.
• Cardiovascular risk beyond LDL: multiple large studies have demonstrated that the TG/HDL ratio is an independent predictor of cardiovascular events, particularly coronary heart disease, in some analyses outperforming LDL cholesterol as a risk predictor.
• Treatment monitoring: because the ratio responds rapidly and measurably to dietary changes, exercise, and metabolic interventions, it is an excellent tool for monitoring treatment effectiveness. Retesting at 8 to 12 weeks after initiating dietary changes provides clear objective feedback.

3. How to Calculate Your TG/HDL Ratio

Step	Action	Example A (Optimal)	Example B (At Risk)
1	Find fasting triglycerides	90 mg/dL	210 mg/dL
2	Find HDL cholesterol	62 mg/dL	38 mg/dL
3	Divide TG by HDL	90 / 62 = 1.45 (Optimal)	210 / 38 = 5.53 (High risk)

This calculation uses mg/dL units. If your lab reports in mmol/L, multiply the ratio by 2.3 to convert to the mg/dL equivalent, or use mmol/L-specific reference ranges (optimal below 0.87 mmol/L equivalent).

4. Standard and Functional Medicine Reference Ranges

TG/HDL Ratio	Conventional Classification	Functional Medicine Interpretation
Below 1.0	Excellent	Ideal: strong insulin sensitivity, large buoyant LDL pattern A likely
1.0 to 2.0	Good	Optimal: good metabolic health, low cardiovascular risk
2.0 to 3.0	Borderline	Borderline: early metabolic dysfunction; dietary optimization indicated
3.0 to 5.0	Elevated risk	Elevated: insulin resistance likely; small dense LDL probable; comprehensive intervention
Above 5.0	High risk	Significant metabolic dysfunction: insulin resistance, atherogenic dyslipidemia; clinical evaluation required

5. Symptoms Associated With an Elevated TG/HDL Ratio

An elevated TG/HDL ratio is largely asymptomatic, which is precisely what makes it dangerous. The metabolic dysfunction it reflects accumulates silently for years before clinical events occur. When symptoms are present, they typically reflect the underlying insulin resistance:

• Abdominal weight gain and difficulty losing weight
• Post-meal fatigue and energy crashes
• Carbohydrate and sugar cravings
• Elevated blood pressure
• Brain fog and poor concentration
• Non-alcoholic fatty liver disease (often discovered incidentally)
• Skin tags (a visible marker of insulin resistance)
• Darkening of skin at neck, armpits, or groin (acanthosis nigricans)
• Fatigue and low energy

6. What Causes an Elevated TG/HDL Ratio

• High refined carbohydrate and sugar intake: the primary driver; dietary carbohydrates are the main substrate for hepatic triglyceride synthesis via de novo lipogenesis; excess sugar, particularly fructose, is uniquely lipogenic
• Insulin resistance and metabolic syndrome: impairs triglyceride clearance and suppresses HDL production
• Physical inactivity: reduces lipoprotein lipase activity (required for TG clearance) and suppresses HDL production
• Excess alcohol consumption: alcohol is directly converted to triglycerides in the liver
• Obesity: particularly visceral adiposity; drives insulin resistance and atherogenic dyslipidemia
• Type 2 diabetes: severely impairs triglyceride metabolism and HDL function
• Hypothyroidism: impairs triglyceride clearance; always evaluate thyroid when TG/HDL is elevated
• Smoking: directly suppresses HDL production
• Low dietary fat intake: paradoxically, very low fat diets often raise triglycerides by shifting caloric intake toward carbohydrates
• Medications: beta-blockers, corticosteroids, thiazide diuretics, oral estrogen, retinoids
• Familial hypertriglyceridemia: genetic predisposition to elevated triglycerides

7. How to Improve This Marker

8. Related Lab Tests

9. When Testing Is Recommended

• All adults; the TG/HDL ratio should be calculated from every fasting lipid panel as a matter of routine
• Anyone with abdominal weight gain, fatigue after meals, or difficulty losing weight
• Family history of cardiovascular disease, type 2 diabetes, or metabolic syndrome
• Patients with "normal" LDL cholesterol but cardiovascular risk factors, to identify occult small dense LDL pattern
• Monitoring response to dietary changes, exercise programs, or metabolic interventions
• Pre-diabetes or borderline fasting glucose; TG/HDL identifies insulin resistance earlier
• PCOS evaluation; atherogenic dyslipidemia is a consistent feature of insulin-resistant PCOS
• Patients on medications known to affect lipids: corticosteroids, beta-blockers, atypical antipsychotics

10. Clinical Perspective

11. Frequently Asked Questions